113 related articles for article (PubMed ID: 2023442)
1. Experimental evaluation of myocardial protective effect of prostacyclin analog (OP-41483) as an adjunct to cardioplegic solution.
Nomura F; Matsuda H; Shirakura R; Ohtani M; Sawa Y; Nakano S; Kawashima Y
J Thorac Cardiovasc Surg; 1991 May; 101(5):860-5. PubMed ID: 2023442
[TBL] [Abstract][Full Text] [Related]
2. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
[TBL] [Abstract][Full Text] [Related]
3. Effects of supplemental L-arginine during warm blood cardioplegia.
Hayashida N; Tomoeda H; Oda T; Tayama E; Chihara S; Akasu K; Kosuga T; Kai E; Aoyagi S
Ann Thorac Cardiovasc Surg; 2000 Feb; 6(1):27-33. PubMed ID: 10748356
[TBL] [Abstract][Full Text] [Related]
4. Relationship of blood flow effects of adenosine during reperfusion to recovery of ventricular function after hypothermic ischemia in neonatal lambs.
Nomura F; Forbess JM; Hiramatsu T; Mayer JE
Circulation; 1997 Nov; 96(9 Suppl):II-227-32. PubMed ID: 9386103
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
6. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
[TBL] [Abstract][Full Text] [Related]
7. Effects of hypercarbic acidotic reperfusion on recovery of myocardial function after cardioplegic ischemia in neonatal lambs.
Nomura F; Aoki M; Forbess JM; Mayer JE
Circulation; 1994 Nov; 90(5 Pt 2):II321-7. PubMed ID: 7955274
[TBL] [Abstract][Full Text] [Related]
8. Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion.
Osaki S; Ishino K; Kotani Y; Honjo O; Suezawa T; Kanki K; Sano S
Ann Thorac Surg; 2006 Jun; 81(6):2167-71. PubMed ID: 16731148
[TBL] [Abstract][Full Text] [Related]
9. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
[TBL] [Abstract][Full Text] [Related]
10. Experimental study of intermittent crossclamping with fibrillation and myocardial protection: reduced injury from shorter cumulative ischemia or intrinsic protective effect?
Bessho R; Chambers DJ
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):528-37. PubMed ID: 10962415
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function.
Fan LL; Sun LH; Li J; Yue XH; Yu HX; Wang SY
Chin Med J (Engl); 1992 Jan; 105(1):11-7. PubMed ID: 1576864
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of prostaglandin I2 analog (OP-41483) on hemodynamics and oxygen metabolism in normothermic liver ischemia.
Saito T
Fukushima J Med Sci; 1993 Jun; 39(1):43-62. PubMed ID: 8125429
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of puerarin against myocardial reperfusion injury. Myocardial metabolism and ultrastructure.
Fan LL; Sun LH; Li J; Yue XH; Yu HX; Wang SY; Dong SQ
Chin Med J (Engl); 1992 Jun; 105(6):451-6. PubMed ID: 1451545
[TBL] [Abstract][Full Text] [Related]
14. Overdose reperfusion of blood cardioplegic solution. A preventable cause of postischemic myocardial depression.
Kofsky ER; Julia PL; Buckberg GD
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):275-83. PubMed ID: 1992238
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2,3-butanedione monoxime in isolated hearts: protection during reperfusion after global ischemia.
Boban M; Stowe DF; Kampine JP; Goldberg AH; Bosnjak ZJ
J Thorac Cardiovasc Surg; 1993 Mar; 105(3):532-40. PubMed ID: 8445931
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
17. [Cardioprotective effects of cariporide as an adjunct in different cardioplegic solutions: an experiment with rabbits].
Zhou RH; Long C; Liu J; Liu B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2320-3. PubMed ID: 18036293
[TBL] [Abstract][Full Text] [Related]
18. Trimetazidine improves recovery during reperfusion in isolated rat hearts after prolonged ischemia.
Ikizler M; Dernek S; Sevin B; Kural T
Anadolu Kardiyol Derg; 2003 Dec; 3(4):303-8. PubMed ID: 14675878
[TBL] [Abstract][Full Text] [Related]
19. Critical timing of nitric oxide supplementation in cardioplegic arrest and reperfusion.
Engelman DT; Watanabe M; Maulik N; Engelman RM; Rousou JA; Flack JE; Deaton DW; Das DK
Circulation; 1996 Nov; 94(9 Suppl):II407-11. PubMed ID: 8901782
[TBL] [Abstract][Full Text] [Related]
20. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
